Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 Jan 22;156(2):61-64.
doi: 10.1016/j.medcli.2020.08.004. Epub 2020 Sep 25.

Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain

[Article in English, Spanish]
Affiliations
Clinical Trial

Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain

[Article in English, Spanish]
Elisabeth Ninchritz-Becerra et al. Med Clin (Barc). .

Abstract

Background: Has been described the loss of smell and taste as onset symptoms in SARS-CoV-2. The objective of this study was to investigate the prevalence in Spain.

Methods: Prospective study of COVID-19 confirmed patients through RT-PCR in Spain. Patients completed olfactory and gustatory questionnaires.

Results: A total of 1043 patients with mild COVID-19 disease. The mean age was 39±12 years. 826 patients (79.2%) described smell disorder, 662 (63.4%) as a total loss and 164 (15.7%) partial. 718 patients (68.8%) noticed some grade of taste dysfunction. There was a significant association between both disorders (p<.001). The olfactory dysfunction was the first symptom in 17.1%. The sQOD-NS scores were significantly lower in patients with a total loss compare to normosmic or hyposmic individuals (p=.001). Female were significantly more affected by olfactory and gustatory dysfunctions (p<.001). The early olfactory recover in 462 clinically cured patients was 315 (68.2%), during the first 4 weeks.

Conclusion: The sudden onset smell and/or taste dysfunction should be considered highly suspicious for COVID-19 infection.

Keywords: Ageusia; Ageusia.; Anosmia; COVID-19; SARS-CoV-2.

PubMed Disclaimer

Figures

Figura 1
Figura 1
Criterios de inclusión y exclusión considerados, así como los datos clínicos y/o subjetivos se obtuvieron mediante la realización de un cuestionario online
None

References

    1. Lechien J.R., Chiesa-Estomba C.M., Place S., Laethem Y.V., Cabaraux P., Mat Q., et al. Clinical and epidemiological characteristics of 1,420 european patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020 doi: 10.1111/joim.13089. - DOI - PMC - PubMed
    1. Vaira L.A., Deiana G., Fois A.G., Pirina P., Madeddu G., De Vito A., et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head & Neck. 2020:1–7. - PMC - PubMed
    1. Lechien J.R., Cabaraux P., Chiesa-Estomba C.M., Khalife M., Hans S., Calvo-Henriquez C., et al. Objective olfactory evaluation of self-reported los of smell in a case series of 86 COVID-19 patients. Head and neck. 2020:1–8. - PMC - PubMed
    1. Bhattacharyya N., Kepnes L.J. Contemporary assessment of the prevalence of smell and taste problems in adults. Laryngoscope. 2015;125:1102–1106. doi: 10.1002/lary.24999. - DOI - PubMed
    1. Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177–1179. doi: 10.1056/NEJMc2001737. - DOI - PMC - PubMed

Publication types

MeSH terms